氟苯尼考磺酸盐在肉鸡体内的药物动力学初步研究

研究氟苯尼考磺酸盐在肉鸡体内的血药浓度及药动学特征。将12只健康三黄肉鸡,单次肌肉注射推荐治疗剂量（20mg／kg）的自制2％氟苯尼考磺酸盐。采用高效液相色谱法测定血浆药物浓度,所得数据用3P97药动软件进行分析后发现,血药浓度和时间关系符合一级吸收一室模型,选择的权重为1／C。主要药动学参数为T1／2kα：（0．28±0．04）h,T1/2Ke：（2．06±0．06）h,Cmax：（4．17±0．12）μg／mL,Tmax：（0．92±0．09）h,AUC：（16．89±0,35）μg／mL,V／F（c）：（3．52±0．13）L／kg,CL／F（s）：（1．19±0．03）L／（kg·h）,Ke：（0．34±0．01）／h,kα：（2．57±0．37）／h,A：（6．56±0．38）μg／mL。结果提示,氟苯尼考磺酸盐在肉鸡体内具有吸收迅速,分布广泛、峰浓度较高以及消除较快的动力学特征。     

氟甲砜霉素（Florfenicol）在猪体内的药物动力学

健康猪6头,体重(24.7±1.0)kg,单剂量静注、肌注、内服氟甲砜霉素(Florfenicol)20mg/kg,用高效液相色谱法测定其血药浓度,实验所得的血药浓度-时间数据采用非房室模型统计矩原理分析处理.静注给药的主要药物动力学参数为AUC90.13mg/(L     

Pharmacokinetics of florfenicol and thiamphenicol in ducks

The pharmacokinetics of florfenicol (FF) and thiamphenicol (TP) after single intravenous (IV) and oral (PO) administration was investigated in Mulard ducks. Both antibiotics were administered at a dose of 30 mg/kg body weight, and their concentrations in plasma samples were assayed using high‐performance liquid chromatography with ultraviolet detection. Pharmacokinetic parameters were calculated using a noncompartmental method. After IV administration, significant differences were found for the mean residence time (2.25 ± 0.21 hr vs. 2.83 ± 0.50 hr for FF and TP, respectively) and the general half‐life (1.56 ± 0.15 hr vs. 1.96 ± 0.35 hr for FF and TP, respectively) indicating slightly slower elimination of TP as compared to FF. The clearance, however, was comparable (0.30 ± 0.07 L/hr/kg for FF and 0.26 ± 0.04 L/hr/kg for TP). The mean volume of distribution was below 0.7 L/kg for both drugs. Pharmacokinetics after PO administration was very similar for FF and TP suggesting minor clinical importance of the differences found in the IV study. Both antimicrobials showed rapid absorption and bioavailability of more than 70% indicating that PO route should be an efficient method of FF and TP administration to ducks under field conditions.     

氟苯尼考纳米晶在鸡体内的药动学

氟苯尼考(florfenicol, FFC)是新型动物广谱抗菌剂,抗菌效果好,广泛应用于牛、羊、猪、水产及禽类等动物细菌性疾病的防制。本试验旨在研究FFC和氟苯尼考纳米晶(florfenicol nanocrystal, FFC-NC)在鸡体内的生物利用度。采用交叉试验法,鸡用药后,在不同时间点翅下静脉采血,利用高效液相色谱法(high performance liquid chromatography, HPLC)测定血浆中FFC含量。结果显示,此试验所建立的HPLC色谱图基线平稳,血浆峰与FFC峰完全分离。回收率和精密度均符合测定要求,重复性好,适用于鸡血浆FFC含量测定。药动学参数结果显示,与FFC组相比,FFC-NC组的达峰时间t_max为(0.875±0.137) h,峰时缩短,药时曲线下面积AUC₍(0-∞))和峰浓度C_max分别为(23.957±2.338) mg/(L·h)和(8.249±0.713) mg/L,FFC-NC组的相对生物利用度是FFC组的3.6倍。结果表明,FFC-NC的药动学特征较FFC均...     

高效液相色谱法测定猪血浆中氟苯尼考的含量

建立了猪血浆中氟苯尼考含量测定的高效液相色谱法(HPLC)。采用C18色谱柱(4.6mm×250mm,5μm),以乙腈-水(24:76)为流动相,流速1.0mL/min,检测波长223nm,进样量20μL,柱温为25℃。氟苯尼考浓度在0.1～16μg/mL时,标准曲线线性关系良好(r0.9998),无杂质干扰,回收率高于94%,批内变异系数和批间变异系数均低于5%。本方法操作简便,分析快速,结果准确,适用于猪血浆中氟苯尼考含量的测定及相关药代动力学研究。     

Pharmacokinetics of florfenicol and its metabolite florfenicol amine in crucian carp (Carassius auratus) at three temperatures after one single intramuscular injection

The pharmacokinetic profiles of florfenicol (FF) or florfenicol amine (FFA) in crucian carp were compared at different water temperatures after single intramuscular administration of FF at 10 mg/kg bodyweight. The concentrations of FF and FFA were determined by a high‐performance liquid chromatography method, and then, the concentration versus time data were subjected to compartmental analysis using a one‐compartment open model. At the water temperatures of 10, 20, and 25°C, the peak concentrations (C_maxs) of FF were 2.28, 2.29, and 2.34 μg/ml, respectively, while those of FFA were 0.42, 0.71, and 0.82 μg/ml, respectively. And the absorption half‐life (t_1/2ka) of FF was 0.21, 0.19, and 0.21 hr, while the elimination half‐life (t_1/2kel) was 31.66, 24.77, and 21.48 hr, respectively. For FFA, the formation half‐life (t_1/2kf) was 3.85, 8.97, and 12.43 hr, while the t_1/2kel was 58.34, 30.27, and 21.22 hr, respectively. The results presented here demonstrated that the water temperature had effects on the elimination of both FF and FFA and the formation of FFA. Based on the T > MIC values calculated here, to treat the infections of bacterial with MIC value ≤ 0.5 μg/ml, FF intramuscularly given at 10 mg/kg bodyweight with a 72‐hr interval is sufficient at the water temperature of 10°C, while the intervals of 60 and 48 hr were needed at 20 and 25°C, respectively. But to treat bacterial with higher MIC values, more FF or FF at 10 mg/kg BW but with shorter intervals should be intramuscularly given to the infected fish.     

Pharmacokinetics of florfenicol after intravenous and intramuscular administration in New Zealand White rabbits

The pharmacokinetic disposition and bioavailability of florfenicol (FF) were determined after single intravenous (i.v.) and intramuscular (i.m.) administrations of 25 mg/kg b.w. to ten healthy New Zealand White rabbits. Plasma FF concentrations were determined by high-performance liquid chromatography (HPLC). The plasma pharmacokinetic values for FF were best described by a one-compartment open model. The elimination half-life (t_1/2β) was different (p < 0.05) however, the area under curve (AUC) was similar (p > 0.05) after i.v. and i.m. administrations. FF was rapidly eliminated (t_1/2β 1.49 ± 0.23 h), slowly absorbed and high (F, 88.75 ± 0.22%) after i.m. injection. In addition, FF was widely distributed to the body tissues (V_ss 0.98 ± 0.05 L/kg) after i.v. injection. In this study the time that plasma concentration exceeded the concentration of 2 μg/mL was approximately 6 h. For bacteria with MIC of 2 μg/mL, frequent administration at this dose would be needed to maintain the concentration above the MIC. However, it is possible that rabbit pathogens may have MIC values less than 2 μg/mL which would allow for less frequent administration. Further studies are necessary to identify the range of MIC values for rabbit pathogens and to identify the most appropriate PK-PD parameter needed to predict an effective dose.     

P and Ca requirements for Japanese quail

Four experiments were conducted to estimate the phosphorus and calcium requirements for weight maintenance and weight gain in Japanese quails during their growth phase from 16 to 36 days. Japanese quails aged 16 days were used for estimating the phosphorous and calcium requirements for weight maintenance or weight gain, with these quails composing each reference slaughter group and the others distributed in a completely randomized design, housed in cages of galvanized wire (33 × 33 × 16 cm) that were stored in acclimatized chambers with specific environmental temperatures. The light programme used during the 20‐day experimental period was 24 h of artificial light. Analysis of the data showed that the prediction equations for estimating the phosphorus and calcium requirements for weight maintenance and weight gain of Japanese quails between 16 and 36 days of age were P (g/quail/day) = P^0.75*(9.3695 + 7.7397*T) + 9.70*WG, in which P is the phosphorus requirement, and Ca (g/quail/day) = P^0.75*(363.99 – 8.0262*T) + 28.15*WG, in which Ca is the calcium requirement, P is BW (kg), T is temperature (°C) and WG (g/quail/day).     

高效液相法测定复方氟苯尼考注射液中氟苯尼考的含量

建立了测定氟苯尼考注射液中氟苯尼考含量的高效液相色谱法。采用C18色谱柱（4.6 mm×150 mm,5μm）,流动相为甲醇∶水（pH值为3.0）为40∶60（v/v）,流速为1 mL/min,检测波长为222 nm,进样10μL,柱温为室温。氟苯尼考浓度在0.1-3 mg/mL范围内,峰面积与浓度的线性关系良好（R^2=0.999 6）;平均回收率为99.49%,RSD为1.12%（n=4）。此法简便、快速、灵敏度高、重现性好。     

氟苯尼考环糊精包合物的药动代谢动力学研究

健康白羽肉鸡20只,随机分为A、B两组,以20mg/kg的剂量单次灌服两种工艺的20%氟苯尼考粉。并于给药后不同时间点从翅下静脉采血,采用已建立的UPLC-MS/MS测定血浆中的药物浓度。采用 WinNonlin 5. 2. 1 药动学分析软件的非房室模型拟合血药浓度-时间数据。结果显示：A组达峰时间(Tmax)和达峰浓度(Cmax)分别为1.675±0.782 h、1073.20±425.72 ng/mL,平均消除半衰期T_1/2λz约为4.729±3.347 h,平均曲线下面积 (AUClast) 为 4498.76±2596.16 h?ng/mL;B组达峰时间(Tmax)和达峰浓度(Cmax)分别为1.523±1.723 h、4654.64±1669.75 ng/mL,平均消除半衰期T_1/2λz约为2.193±1.515 h,平均曲线下面积 (AUClast)为15392.84±2586.10 ng/mL;相对生物利用度约为342.16%。结果表明,采用环糊精包合工艺的氟苯尼考粉的生物利用度显著高于普通工艺的氟苯尼考粉。     

氟苯尼考耐药性研究进展

氟苯尼考由于其广谱、高效的特性而广泛使用于兽医临床.然而,最近几年氟苯尼考在不少菌群中出现的耐药性问题已引起了人们的普遍关注.本文综述了国外近几年对氟苯尼考在大肠杆菌、沙门氏菌和葡萄球菌属耐药性方面的研究进展.     

新型兽用纳米乳载药系统在大鼠体内的药代动力学研究

为了解氟苯尼考纳米乳(FFNE)在大鼠体内药代动力学行为,本试验以氟苯尼考溶液(FFSol)为参比制剂,以30 mg/kg剂量给大鼠灌胃和肌内注射给药,分别于给药后0.5、1、2、4、8、12、24、36、48、72 h采血,利用高效液相色谱法测定血浆中氟苯尼考含量,利用DAS 2.0软件计算房室模型与非房室模型条件下药代动力学参数。结果显示,在两种给药方式下,FFNE与FFSol在大鼠体内均符合二室模型。灌胃给药后,FFNE与FFSol在房室模型条件下AUC_(0-∞)分别为1 085.047和2 176.490 mg/L·h,半衰期分别为10.566和13.687 h,FFNE的相对生物利用度为187.4%。肌内注射给药后,FFNE与FFSol在房室模型条件下AUC_(0-∞)分别为1 530.55和3 243.338 mg/L·h,半衰期分别为7.533和13.335 h,FFNE的相对生物利用度为211.9%。结果表明,FFNE通过灌胃和肌内注射给药在大鼠体内分布较广,灌胃相对肌内注射吸收差,消除快。将氟苯尼考制成纳米乳剂后促进了氟苯尼考的吸收,氟苯尼考的生物利用度显著提高。     

Comparative pharmacokinetics of florfenicol in healthy and Pasteurella multocida‐infected Gaoyou ducks

Pasteurella multocida is the causative agent of fowl cholera, and florfenicol (FF) has potent antibacterial activity against P. multocida and is widely used in the poultry industry. In this study, we established a P. multocida infection model in ducks and studied the pharmacokinetics of FF in serum and lung tissues after oral administration of 30 mg/kg bodyweight. The maximum concentrations reached (C_max) were lower in infected ducks (13.88 ± 2.70 μg/ml) vs. healthy control animals (17.86 ± 1.57 μg/ml). In contrast, the mean residence time (MRT: 2.35 ± 0.13 vs. 2.27 ± 0.18 hr) and elimination half‐life (T_½β: 1.63 ± 0.08 vs. 1.57 ± 0.12 hr) were similar for healthy and diseased animals, respectively. As a result, the area under the concentration curve for 0–12 hr (AUC_0–12 hr) for FF in healthy ducks was significantly greater than that in infected ducks (49.47 ± 5.31 vs. 34.52 ± 8.29 μg hr/ml). The pharmacokinetic differences of FF in lung tissues between the two groups correlated with the serum pharmacokinetic differences. The C_max and AUC_0–12 hr values of lung tissue in healthy ducks were higher than those in diseased ducks. The concentration of FF in lung tissues was approximately 1.2‐fold higher than that in serum both in infected and healthy ducks indicating that FF is effective in treating respiratory tract infections in ducks.     

Characterization of the cathelicidin cluster in the Japanese quail (Coturnix japonica)

The Japanese quail has several advantages as a low‐fat meat bird with high immunity against diseases. Cathelicidins (CATHs) are antimicrobial peptides that play an important role in innate immunity. The aim of this study was to characterize the CATH cluster in the Japanese quail (Coturnix japonica). The Japanese quail CATH (CjCATH) cluster, contains four CATH genes, as in the chicken. The coding sequences of CjCATHs exhibited >85.3% identity to chicken CATHs. The predicted amino acid sequences of the four CjCATH genes contained the cathelin‐like domain characteristic of CATH proteins. Polymorphisms were detected in the open reading frames (ORFs) of all CjCATH sequences. Two amino acid substitutions were observed in the antimicrobial region of the mature peptide of CjCATH2, and predicted to influence peptide function. CjCATH1 is expressed in lung, heart, bone marrow and bursa of Fabricius (BF). CjCATH2 is expressed in bone marrow. CjCATH3 is expressed in lung, heart, bone marrow, BF, tongue and duodenum. CjCATHB1 is expressed in bone marrow and BF. This study is the first to characterize CATH genes in the Japanese quail, and identifies novel antimicrobial peptide sequences belonging to the cathelicidin family, which may play a role in immunity in this species.     

Oral thyroxine administration mimics photoperiodically induced gonadal growth in Japanese quail

Most temperate‐zone animals are seasonal breeders. In a previous study, it was found that light‐induced hormone conversion of thyroxine (T₄) prohormone to active 3,5,3′‐triiodothyronine (T₃) in the mediobasal hypothalamus regulates photoperiodic response of gonads in Japanese quail. Here the effect of T₄ or T₃, administered in drinking water, on testicular growth in the Japanese quail kept under short days is shown. Testicular length was significantly increased in birds given T₄ at doses of 4, 8 and 10 mg/L, while any dose of T₃ had little effect on testicular growth. High doses (8 and 10 mg/L) of T₄ and T₃ resulted in high mortality and/or reduction of bodyweight. Among all of the treatment, 4 mg/L of T₄ was the most effective on photoperiodic testicular growth, which caused little reduction in bodyweight. These data provide a new conventional method for promoting gonadal growth under short days.     

Genetic evaluation of weekly body weight in Japanese quail using random regression models

1. A total of 11 826 records from 2489 quails, hatched between 2012 and 2013, were used to estimate genetic parameters for BW (body weight) of Japanese quail using random regression models. Weekly BW was measured from hatch until 49 d of age. WOMBAT software (University of New England, Australia) was used for estimating genetic and phenotypic parameters.

2. Nineteen models were evaluated to identify the best orders of Legendre polynomials. A model with Legendre polynomial of order 3 for additive genetic effect, order 3 for permanent environmental effects and order 1 for maternal permanent environmental effects was chosen as the best model.

3. According to the best model, phenotypic and genetic variances were higher at the end of the rearing period. Although direct heritability for BW reduced from 0.18 at hatch to 0.12 at 7 d of age, it gradually increased to 0.42 at 49 d of age. It indicates that BW at older ages is more controlled by genetic components in Japanese quail.

4. Phenotypic and genetic correlations between adjacent periods except hatching weight were more closely correlated than remote periods. The present results suggested that BW at earlier ages, especially at hatch, are different traits compared to BW at older ages. Therefore, BW at earlier ages could not be used as a selection criterion for improving BW at slaughter age.     

氟苯尼考粉中非法添加四种喹诺酮类药物的HPLC检测方法研究

建立了高效液相色谱法检测氟苯尼考粉中非法添加氧氟沙星、诺氟沙星、环丙沙星、恩诺沙星的方法.用十八烷基键合硅胶色谱柱,以A(磷酸3.0 mL加水至1000 mL,三乙胺调pH值至3.0±0.1,加乙腈50 mL)-甲醇(88:12)为流动相,采用二极管阵列检测器,采集波长为200 ～400nm,分辨率1.2 am,记录光谱图和283 nm波长处的色谱图,流速1.0 mL/min,柱温30℃.结果显示,4种喹诺酮类药物的浓度在0.5 ～ 200 μg/mL范围内呈良好的线性关系,添加回收率在98.5％ ～100.9％之间,相对标准偏差在0.14％ ～ 0.74％之间,检测限0.5 mg/g.本方法快速、准确,可用于氟苯尼考粉中非法添加喹诺酮类药物的定性和定量检测.     

CXCL14-like immunoreactivity in somatostatin-producing cells of the Japanese quail (Coturnix japonica) pancreas

This study examines chemokine CXCL14-like peptide distribution in the Japanese quail (Coturnix japonica) pancreas using a specific anti-human CXCL14 antibody. CXCL14-immunoreactive cells were observed in the pancreatic islet peripheral region. The staining was abolished after pre-absorbing the antibody with recombinant human CXCL14. CXCL14-immunoreactive cells were immuno-positive for somatostatin, but not glucagon and insulin. CXCL14 secreted from somatostatin-producing cells might participate in insulin secretion modulation together with somatostatin. In addition, CXCL14 might participate in glucose homeostasis in co-operation with somatostatin and growth hormone.